Antitumour and toxic effects on Wistar rats of two new platinum complexes

European Journal of Clinical Investigation

Volumn 32, Issue 2, 2002, Pages 129-133

  Charalabopoulos, K ^a,b,c   Karkabounas, S ^a,b   Ioachim, E ^a,b   Papalimneou, V ^a,b   Syrigos, K ^a,b   Evangelou, A ^a,b   Agnantis, N ^a,b   Hadjiliadis, N ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

^c NONE   (Greece)

Author keywords

Cancer; Cisplatin; Survival; Wistar rats

Indexed keywords

ALANINE DERIVATIVE; BENZO[A]PYRENE; INOSINE DERIVATIVE; PLATINUM COMPLEX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; BODY TEMPERATURE; CANCER CHEMOTHERAPY; CHROMATOGRAPHY; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG PURIFICATION; DRUG SAFETY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG WITHDRAWAL; EXPERIMENTAL NEOPLASM; HAIR LOSS; HEMATURIA; HEMOLYSIS; HYPERTHERMIA; LEUKOCYTE COUNT; LIVER TOXICITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN;

ANIMALS; ANTINEOPLASTIC AGENTS; BENZO(A)PYRENE; HEMATURIA; HEMOLYSIS; HUMANS; LEUKOPENIA; LIVER; MALE; ORGANOPLATINUM COMPOUNDS; RATS; RATS, WISTAR; SARCOMA, EXPERIMENTAL;

EID: 0037000593     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2002.00932.x     Document Type: Conference Paper

References (19)

1. Pestayko AW, Croole ST, Carter SK. Cisplatin, Current Status and New Developments. New York: Academic Press; 1980.
2. Barnard CFJ, Cleare MJ, Hydes PC. Second generation anticancer platinum compounds. Chem Br 1986;22:1001-4.
3. Recchia F, Sica G, De Fillippis S, Resselli M, Saggio G, Guerriero G et al. Cisplatin, vindesine, mitomycin-c and B-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study. Anticancer Res 2000;20:1985-90.
4. Sharman SE, Lippard SJ. Structural aspects of platinum anticancer drug interactions with DNA. Chem Rev 1987;87:1153-81.
5. Aletras V, Hadjiliadis D, Hadjiliadis N. On the mechanism of action of the antitumor drug cis-platin (cis-DDP) and its second generation derivatives. Metal Based Drugs 1995;2:153-85.
6. Köpf Maier P, Kopf H. Non-platinum group metal antitumor agents: history, current status and perspectives. Chem Rev 1987;87:1137-52.
7. Kepler BK. Metal complexes in cancer chemotherapy. Weinheim: Verlag Chemie; 1993.
8. Hadjiliadis N, Theophanides T. Platinum purine nucleosides II. Interaction of k2PtX4 (X=Cl, Br) with inosine and guanosine. Inorg Clin Acta 1976;16:77-88.
9. 3). Inorg Chim Acta 1989;164:221-9.
10. Kallistratos G, Fasske E, Karkabounas S, Charalabopoulos K. Prolongation of the survival time of tumor bearing wistar of the simultaneous oral administration of vitamins C+E and selenium with glutathione. Progr Clin Biol Res 1989;259:377-89.
11. Kallistratos G, Evangelou A, Agnantis N, Fasske E, Karkabounas S, Donos A. Enhancement of the antineoplastic effect of anticarcinogens on benzo(a)pyrene treated rats, in relation to their number and biological activity. Cancer Lett 1994;82:153-65.
12. Clark Still W, Kahn M, Mitra A. Rapid chromographic technique for preparative separations with moderate resolution. J Org Chem 1978;43:2923-5.
13. Rosenberg B, van Camp L, Krigas T. Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode. Nature 1965;205:689-701.
14. Rosenberg B, van Camp L, Trosko JE, Mansour VH. Platinum compounds: a new class of protein antitumour agents. Nature 1969;222:385-9.
15. Zylberberg B, Dormont D, Tankewitz S, Darai E, Modelenat P, Antoine JM. Secondary cytoreductions in the treatment of ovarian cancers. Gynecol Obstet Fertil 2000;28:127-36.
16. Lopervite M, Favoni RE, de Cupis A, Pirani P, Merlo F, Crossi F et al. Preclinical evaluation of new antineoplastic agents in NSCLL cell lines: evidence of histological subtype-dependent cytotoxicity. Int J Oncol 1999;15:787-92.
17. Warszawski N, Link KH, Warszawski A, Lutz MP, Gansange F, Schneider BM et al. Effect of therapy on survival of patients with pancreatic carcinoma. Strahlenther Onkol 1999;175:315-19.
18. Cmyrek R, Beer R, Elizeri Y, Oster MW, Silvers DN, Schneiderman P et al. Invasive squamous cell carcinoma with sporotrichoid metastasis in a patient with cutaneous T cell lymphoma treated with chronic extracorporeal photopheresis. Cutis 1999;64:261-4.
19. Newton K, Strasser A. Ionizing radiation and chemotherapeutic drugs induce apoptosis in lymphocytes in the absence of Fas or FADD/MORT 1 signaling. Implication for cancer therapy. J Exp Med 2000;191:195-200.